Aldose reductase inhibition improves nerve conduction velocity in diabetic patients
RG Judzewitsch, JB Jaspan, KS Polonsky, CR Weinberg, JB Halter, E Halar, MA Pfeifer, C Vukadinovic, L Bernstein, M Schneider, KY Liang, KH Gabbay, AH Rubenstein, and D Porte
To assess the potential role of polyol-pathway activity in diabetic neuropathy, we measured the effects of sorbinil--a potent inhibitor of the key polyol-pathway enzyme aldose reductase--on nerve conduction velocity in 39 stable diabetics in a randomized, double-blind, cross-over trial. During nine weeks of treatment with sorbinil (250 mg per day), nerve conduction velocity was greater than during a nine-week placebo period for all three nerves tested: the peroneal motor nerve (mean increase [+/- S.E.M.], 0.70 +/- 0.24 m per second, P less than 0.008), the median motor nerve (mean increase, 0.66 +/- 0.27, P less than 0.005), and the median sensory nerve (mean increase, 1.16 +/- 0.50, P less than 0.035). Conduction velocity for all three nerves declined significantly within three weeks after cessation of the drug. These effects of sorbinil were not related to glycemic control, which was constant during the study. Although the effect of sorbinil in improving nerve conduction velocity in diabetics was small, the findings suggest that polyol-pathway activity contributes to slowed nerve conduction in diabetics. The clinical applicability of these observations remains to be determined, but they encourage further exploration of this approach to the treatment or prevention of diabetic neuropathy.
This article has been cited by other articles:
Ho, E. C.M., Lam, K. S.L., Chen, Y. S., Yip, J. C.W., Arvindakshan, M., Yamagishi, S.-I., Yagihashi, S., Oates, P. J., Ellery, C. A., Chung, S. S.M., Chung, S. K.
(2006). Aldose Reductase-Deficient Mice Are Protected From Delayed Motor Nerve Conduction Velocity, Increased c-Jun NH2-Terminal Kinase Activation, Depletion of Reduced Glutathione, Increased Superoxide Accumulation, and DNA Damage.. Diabetes
55: 1946-1953
[Abstract][Full Text]
Price, S. A., Agthong, S., Middlemas, A. B., Tomlinson, D. R.
(2004). Mitogen-Activated Protein Kinase p38 Mediates Reduced Nerve Conduction Velocity in Experimental Diabetic Neuropathy: Interactions With Aldose Reductase. Diabetes
53: 1851-1856
[Abstract][Full Text]
Greene, D. A., Arezzo, J. C., Brown, M. B.
(1999). Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Neurology
53: 580-580
[Abstract][Full Text]
Aida, K., Tawata, M., Ikegishi, Y., Onaya, T.
(1999). Induction of Rat Aldose Reductase Gene Transcription Is Mediated through the cis-Element, Osmotic Response Element (ORE): Increased Synthesis and/or Activation by Phosphorylation of ORE-Binding Protein Is a Key Step. Endocrinology
140: 609-617
[Abstract][Full Text]
Yabe-Nishimura, C.
(1998). Aldose Reductase in Glucose Toxicity: A Potential Target for the Prevention of Diabetic Complications. Pharmacol. Rev.
50: 21-34
[Abstract][Full Text]
Clark, C. M., Lee, D. A.
(1995). Prevention and Treatment of the Complications of Diabetes Mellitus. NEJM
332: 1210-1217
[Full Text]
Broadstone, V. L., Greene, D. A., Cyrus, J., Pfeifer, M. A.
(1987). Diabetic Peripheral Neuropathy Part I: Sensorimotor Neuropathy. The Diabetes Educator
13: 30-35
Previous
